A Missouri judge has given final approval to Bayer’s $7.25 billion settlement of lawsuits alleging that its Roundup weedkiller causes cancer, a decision that could ultimately resolve litigation that has weighed on the German company for close to a decade.
Judge Timothy Boyer, of a state court in St Louis, found the settlement “fair, reasonable, and adequate” on Friday, Reuters reported. The deal, announced in February, aims to resolve nearly all current and future Roundup claims in the United States.
Bayer is facing approximately 65,000 claims in US state and federal courts from plaintiffs who say they developed cancer after using Roundup at home or on the job. The settlement offers payouts ranging from $10,000 to $165,000 to people who were exposed to the weedkiller and developed non-Hodgkin lymphoma, a form of cancer. The exact award will depend on factors including the severity of the person’s cancer, how old they were when they were diagnosed, and whether they were exposed to Roundup at home or at work.
The litigation has weighed on Bayer since its 2018 acquisition of Monsanto, costing the company billions of dollars and driving down its share price. The company previously spent about $10 billion in 2020 to resolve most of the lawsuits then outstanding, but it was unable to gain court approval of a parallel $1.25 billion settlement that would have resolved future Roundup claims. Bayer has denied the claims and said that decades of studies have shown Roundup’s key ingredient, glyphosate, is safe and does not cause cancer.
The deal reached the court after Bayer won a US Supreme Court ruling on whether it could be sued over Roundup’s government-approved warning label, a decision that undercut a central claim in many of the lawsuits. Lawyers for plaintiffs who support the settlement have said the deal ensures that people with cancer will get paid at a time when litigation is more uncertain than ever. Opponents argued that the deal does not offer enough money, and said it is designed to trap current and future claimants who would prefer to pursue their lawsuits in court.
The deal excludes lawsuits that have been consolidated in an ongoing federal court proceeding. Bayer says about 200 of those cases are still being litigated, and it has argued that the Supreme Court’s ruling gives it strong defences to those cases. Judge Boyer had given the settlement preliminary approval in March, triggering a provision requiring Bayer to pay $500 million into a fund within 10 days to cover costs such as notifying class members of the deal.
Sources: Reuters — “Missouri judge approves Bayer’s $7.25 billion Roundup settlement”, https://www.reuters.com/legal/government/missouri-judge-approves-bayers-725-billion-roundup-settlement-2026-11-20/
